بر اساس عنوان

1
History matching of fracture distributions by ensemble Kalman filter combined with vector based level set parameterization
2
History matching of naturally fractured reservoirs based on the recovery curve method
3
History matching of petroleum reservoir models by the Ensemble Kalman Filter and parameterization methods
4
History matching production data and uncertainty assessment with an efficient TSVD parameterization algorithm
5
History matching with iterative Latin hypercube samplings and parameterization of reservoir heterogeneity
6
History matters in Greece: The adoption of Internet-enabled computers by small and medium sized enterprises
7
History matters: The inherited disciplinary structure of the post-communist science in countries of central and eastern Europe and its restructuring
8
History may be the best guide for determining the athlete’s dietary protein needs
9
History of a pine false webworm (Hymenoptera: Pamphiliidae) outbreak in northern New York
10
History of abortion, preterm, term birth, and risk of preeclampsia: A population-based study
11
HISTORY OF ACADEMIC NEUROLOGY IN LATVIA
12
History of accumulation of mercury and nickel in Thane Creek, Mumbai, using 210Pb dating technique
13
History of adenomyosis
14
History of Agricultural Water Management
15
History of alcohol or drug problems, current use of alcohol or marijuana, and success in quitting smoking
16
History of an Indian Library and Challenges for Today Original Research Article
17
History of Anesthesia and Pain in Old Iranian Texts
18
History of anthropogenic nitrogen input to the German Bight/SE North Sea as reflected by nitrogen isotopes in surface sediments, sediment cores and hindcast models
19
History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: the WISE study
20
History of Aral Sea level variability and current scientific debates
21
history of arrival and development of chinese ethnic in kupang
22
History of Asian eolian input to the West Philippine Sea over the last one million years
23
History of atmospheric environment
24
History of bioavailable lead and iron in the Greater North Sea and Iceland during the last millennium – A bivalve sclerochronological reconstruction
25
History of Blackwater Fever in Northern Nigeria from 1900-1918
26
History of Bone Fracture: Treatment and
27
History of breastfeeding and medical profession
28
History of calcitonin
29
History of cancer and mortality in community-dwelling older adults
30
History of Cancer in Iran
31
History of childhood abuse in Portuguese parents
32
History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder
33
History of childhood candy cigarette use is associated with tobacco smoking by adults
34
History of Cholera Outbreaks in Iran during the 19th and 20th Centuries
35
History of CHP developments and current trends
36
History of clinical identification of West syndrome – in quest after the classic
37
History of Contraposition in Ancient Logic
38
History of cosmic ray influence on ozone layer-key steps Original Research Article
39
History of cosmic ray research in Finland Original Research Article
40
History of criminal justice : By Herbert A. Johnson and Nancy Travis Wolfe Anderson Publishing Co. (P.O. Box 1576, Cincinnati, Ohio 45201-1576), 1995, 284 pp., softcover—$31.95
41
History of crustal growth and recycling at the Pacific convergent margin of South America at latitudes 29°–36° S revealed by a U–Pb and Lu–Hf isotope study of detrital zircon from late Paleozoic accretionary systems
42
History of cryogenics: the epoch of the pioneers from the beginning to the year 1911
43
History of Darwinʹs Laboratory
44
History of deliberate self-harm and its association with mood fluctuation
45
History of depression and subsyndromal depression in women smokers
46
History of depression and womenʹs current health and functioning during midlife
47
History of depression prior to Alzheimerʹs disease and vascular dementia verified post-mortem
48
History of depression, angina, and quality of life after acute coronary syndromes
49
History of depressive episodes as a risk factor for illness severity in early inflammatory arthritis
50
History of Dermal and Subdermal Injectable Fillers Before Collagen: The Early Years
51
History of development and application of gamma-ray imagers in Russia since 1986
52
History of development and application of gamma-ray imagers in Russia since 1986
53
History of diamond-like carbon films — From first experiments to worldwide applications
54
History of disorders of thyroid dysfunction
55
History of Drainage in the Bureau of Reclamation
56
History of Electrical Aerosol Measurements
57
History of electricity network control and distributed generation in the UK and Western Denmark
58
History of Fertility and Coronary Artery Disease in Iranian Women Older than 5o Years Old
59
History of food acceptance research in the US Army
60
History of Four Early Journals Publication in Academy of Islamic Studies, University of Malaya
61
History of fractures age 20–50 years is a ris factor for subsequent fractures after age 5 years.
62
History of freshwater runoff across the Laptev Sea (Arctic) during the last deglaciation
63
History of Gas in Geothermal Fluids, Krafla, Northeast Iceland
64
History of headache in medieval Persian medicine
65
History of history and canons of design
66
History of human activity in coastal southern Brazil from sediment
67
History of hydrocarbon accumulations spanning important tectonic phases in marine sedimentary basins of China: Taking the Tarim Basin as an example
68
History of hypertension has a great predictive value toward one-year mortality after acute myocardial infarction, but only in patients with microalbuminuria
69
History of Iatrogenic Disease
70
History of ice rafting at South Atlantic ODP Site 177-1092 during the Gauss and Late Gilbert Chrons
71
History of ice sheet elevation in East Antarctica: Paleoclimatic implications
72
History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder
73
History of Immunology: Paul Ehrlich: The Founding of Pediatric Immunology
74
History of Indo-Pacific coral reef systems since the last glaciation: Development patterns and controlling factors
75
History of inductively coupled plasma mass spectrometry-based immunoassays
76
History of inductively coupled plasma mass spectrometry-based immunoassays
77
History of Influenza: Pandemics in Iran and the World
78
History of informed medical consent
79
History of informed medical consent
80
History of informed medical consent
81
History of insect parasitism in Italy
82
History of Islamic Education System in Kuala Lumpur
83
History of Japan–U.S./High Pressure Mineral Physics Seminars: 1976 to 2012
84
History of kidney stones as a possible risk factor for chronic kidney disease
85
History of land use in India during 1880–2010: Large-scale land transformations reconstructed from satellite data and historical archives
86
History of lasers in dermatology
87
History of Lead Pollution Recorded in East China Sea Sediments
88
History of Leukemia: Diagnosis and Treatment from Beginning to Now
89
History of libraries in the western world : Harris, Michael H. (4th ed.). Metuchen, NJ: Scarecrow Press, 1995. 301 pp. $39.50 (ISBN: 0-8108-2972-X).
90
HISTORY OF LICHENOLOGY IN IRAN, WITH SOME ADDITIONAL LICHENS FROM GOLESTAN PROVINCE, (N. IRAN)
91
History of life (2nd edition): By Richard Cowen. Blackwell, London, 1990. Paperback, 462 pp, Price £29.50, ISBN: 0-86542-354-7
92
History of Literary Translation from Tatar Language to Russian in the XX Century
93
HISTORY OF LOOK-TO-THE EAST IDEA DURING TUNKU ABDUL RAHMAN’S ERA
94
History of macroeconometric modelling: lessons from past experience
95
History of magnetic disk storage based on perpendicular magnetic recording
96
History of major depressive disorder among smokers in cessation twreatment: Associations with dysfunctional attitudes and coping
97
History of manic and hypomanic episodes and risk of incident cardiovascular disease: 11.5 year follow-up from the Baltimore Epidemiologic Catchment Area Study
98
History of marijuana use and tobacco smoking topography in tobacco-dependent adolescents
99
History of mathematical-chemistry in Iran: Scientific works of Alireza Ashrafi
100
History of Medical Informatics in Croatia
101
History of Medical Informatics in Europe - a Short Review by Different Approach
102
History of medical involvement in torture—then and now
103
History of Medical Parasitology and Parasitic Infections in Iran
104
History of Medical Sciences in Iran
105
History of Medicine in Iran The Oldest Known Medical Treatise in the Persian Language
106
History of Medicine in Iran: A Brief History of Plastic Surgery in Iran
107
History of Medicine in Islamic Iran
108
History of Memory
109
History of menstrual disorders associated with gestational diabetes mellitus
110
History of MHD power plant development
111
History of migraine and risk of cerebral ischaemia in young adults
112
History of Missionary Activities in Diyarbakır
113
History of mitral valve anterior leaflet repair with triangular resection
114
History of multidisciplinary public health mini-symposium
115
History of Multiple Sclerosis in Iran
116
History of Neoproterozoic rift basins in South China: implications for Rodinia break-up
117
History of Neurological Disorders in Persian Medicine
118
History of nitrous oxide—with special reference to its early use in Germany
119
History of nutrition in space flight: Overview
120
History of Ocular Trauma in Tehran Population: Tehran Eye Study
121
History of offshoring knowledge services
122
History of offshoring knowledge services
123
HISTORY OF ORTHOPEDICS IN IRAN
124
History of pancreatic head resection—the evaluation of surgical technique
125
History of Pediatric Adolescent Gynecology Revisited
126
HISTORY OF PEDIATRIC NEPHROLOGY IN IRAN
127
History of Pelagianism and its Doctrines
128
History of physical and/or sexual abuse and current suicidality in college women
129
History of plains resurfacing in the Scandia region of Mars
130
History of planetary science. The Pic du Midi Planetary Observation Project : 1941–1971
131
History of plasticity and metal forming analysis
132
History of potato wart disease in Europe – a proposal for harmonisation in defining pathotypes
133
History of Primary Immunodeficiency Diseases in Iran
134
History of Rabies in Traditional Medicine’s Resources and Iranian Research studies: On the Occasion of the World Rabies Day (September 28, 2012)
135
History of recurrent miscarriage in traditional Chinese medicine literature
136
History of Russian Underwater Acoustics, Oleg Q. Godin, David R. Palmer. World Scientific Publisher Ltd., UK (2008). 1211pp., ISBN: 9789812568250
137
History of safe use as applied to the safety assessment of novel foods and foods derived from genetically modified organisms
138
History of sexual abuse and obesity treatment outcome
139
History of shoulder and elbow surgery: 100, 75, 50, and 25 years ago in North America
140
History of skin transplantation
141
History of Sleeping Sickness in East Africa
142
History of Small for Gestational Age at Birth With Verbal and Non-verbal Intelligence: A Case-Control Study Among Preschool Children
143
History of smoking and postcessation weight gain among weight loss surgery candidates
144
History of Sport Participation in Relation to Obesity and Related Health Behaviors in Women
145
History of Sports Medicine and Successful Career in Orthopedic Sports Medicine
146
History of Star Formation of the Galaxy Cluster Abell 85
147
History of star formation rate and luminosity density of galaxies Original Research Article
148
History of study and checklist of the scorpion fauna (Arachnida: Scorpiones) of Iran
149
History of Success andCurrentContext in Problem Solving:Combined Influences on Operator Selection
150
History of Suicide Attempt Is Associated with Reduced Medial Prefrontal Cortex Activity during Emotional Decision-Makingamong Men with Schizophrenia: An Exploratory fMRI Study
151
History of suicide attempts among patients with depression in the GENDEP project
152
History of surface weather observations in the United States
153
History of target making activities at ORNL from 1957 to 1996
154
History of target making activities at ORNL from 1957 to 1996
155
History of tectonic interpretations of the Alps
156
History of telescopic observations of the Martian satellites
157
History of the accumulation of trace metals in sediments of the saline Rogoznica Lake (Croatia)
158
History of the American Board of Preventive Medicine Review Article
159
History of the Antarctic Peninsula Ice Sheet since the early Pliocene—Evidence from cosmogenic dating of Pliocene lavas on James Ross Island, Antarctica
160
History of the atmospheric deposition of major and trace elements in the industrialized St. Lawrence Valley, Quebec, Canada
161
History of the Basics of Sovereignty and Research on the Establishment of the Government (Relying on the Established Government in the Safavid Era)
162
History of the clinical use of botulinum toxin A and B
163
History of the Criteria for Lunar Crescent Visibility in Malaysia
164
History of the cultural layer in Moscow and accumulation of anthropogenic substances in it
165
History of the department of surgery in Cincinnati
166
History of the evolution of echocardiography
167
History of the exploitation of thermo-mineral resources in Campi Flegrei and Ischia, Italy
168
History of the inflow of the warm Tsushima Current into the Sea of Japan between 3.5 and 0.8 Ma
169
History of the journal impact factor: Contingencies and consequences
170
History of the recognition of organic geochemistry in geoscience
171
History of the Representation of the DDC in the MARC Classification Format
172
History of the Rights to Self-Determination of Indigenous Peoples under International Law
173
History of the School of Public Health and Institute of Public Health Research of Tehran University
174
History of the search for continuous melting
175
History of the solar ponds: A review study
176
History of the South Java Current over the past 80 ka
177
History of the stiffness method
178
History of the treatment of childhood ALL: A paradigm for cancer cure
179
History of the Triumphs of Our Holy Faith Amongst the Most Barbarous and Fierce Peoples of the New World
180
History of the tuberous sclerosis complex
181
History of the West of Scotland Plastic Surgery Unit: 1940–1986
182
History of thymoma and yellow fever vaccination
183
History of torture
184
History of torture
185
History of treatments
186
History of Tropical Medicine: William Ernest Cooke, FRCSI (1879–1967) and his Asian tour of 1929–1930
187
History of tropospheric ozone for the San Bernardino Mountains of Southern California, 1963–1999
188
History of Tumescent Anesthesia, Part I: From American Surgical Textbooks of the 1920s and 1930s, ,
189
History of umbilical cord blood transplantation
190
History of upper gastrointestinal cancers in relatives: A communitybased estimate
191
History of upwelling in the Tropical Eastern Pacific and the paleogeography of the Isthmus of Panama
192
History of urinary tract infections and risk of renal cell carcinoma
193
History of use and abuse of X-ray: the early 20th century Italian pediatrics school
194
History of water-column anoxia in the Black Sea indicated by pyrite framboid size distributions
195
HISTORY OF WHEAT BREEDING IN LATVIA
196
History on Trial
197
History on Trial
198
History on Wikipedia: In need of a NWICO (New World Information and Communication Order)? the case of Cambodia
199
History plotting tool for Data Quality Monitoring
200
History plotting tool for Data Quality Monitoring
201
History recovery and source identification of multiple gaseous contaminants releasing with thermal effects in an indoor environment
202
History rediscovered: Welcome to 139 years of The Veterinary Journal
203
History repeating
204
History repeating. The plague of 1630 in Milan and the COVID-19 pandemia
205
History repeats itself: The failure of rational choice models in corporate governance
206
History Rewritten in a Postmodern Novel: Opposed Views on History in Jeanette Winterson’s The Passion
207
History Run Wild: The Alternate World of Joan Aiken’s The Wolves of Willoughby Chase Series
208
History through the eyes of the eyes
209
History versus expectations: Increasing returns or social influence?
210
History Writing That’s ‘‘Good to Think With’’: The Great Fire, Blizzard! and An American Plague
211
History, agency and political struggle: a different view
212
History, challenges and perspectives of cell microencapsulation
213
History, chemistry and biology of alkaloids from Lobelia inflata
214
History, collective memory and identity: the Tatars of sovereign Tatarstan
215
History, concept and spectrum of rheumatism, challenges in understanding
216
History, current state, and future of oil/gas industry in Russia. Academy of natural sciences of Russia, Moscow (1995)
217
History, current state, and future of oil/gas industry in Russia. Academy of natural sciences of Russia, Moscow (1995)
218
History, current state, and future of oil/gas industry in Russia. Academy of natural sciences of Russia, Moscow (1995)
219
History, current status, and collaborative research projects for Bemisia tabaci
220
History, development, and a new concept of phthalocyanines in Turkey
221
History, distance and text: narratives of the 1853–1854 Perry expedition to Japan
222
History, meaning, and interpretation: a critical response to Bevir
223
History, memory, and justice: The Touvier trial in France
224
HISTORY, MORPHOLOGY AND PERFECT PROPORTIONS OF MUGHAL TOMBS: THE SECRET TO CREATION OF TAJ MAHAL
225
History, Narrative, and Photography in W. G. Sebalds Die Ausgewanderten
226
History, narrative, and time
227
History, opportunities and challenges for biological control in Australia, New Zealand and the Pacific islands
228
History, origin and extent of soil erosion on Easter Island (Rapa Nui)
229
HISTORY, POLITICS, AND CLAIMS OF MAN-MADE GLOBAL WARMING
230
History, principles, and practice of health and human rights
231
History, Structure and Agency in Global Health Governance; Comment on “Global Health Governance Challenges 2016 – Are We Ready?”
232
History, Studies and Specific Uses of Repetitive Transcranial Magnetic Stimulation (rTMS) in Treating Epilepsy
233
History, the kidney, and hypertension in blacks versus whites
234
History/ Fiction: An Intertextual reading of E. L. Doctorow’s Ragtime
235
History’s Worst Inventions and the People Who Made Them. Chaline, Eric. New Holland Publishers, UK, Ltd. (2009). £10.99, ISBN: 978 1 84773 505 8.
236
History-based price discrimination and entry in markets with switching costs: A welfare analysis
237
History-dependence of isometric muscle force: Effect of prior stretch or shortening amplitude
238
History-dependent magnetic properties in pure and Zn-doped cupric oxide
239
History-dependent modified sliding mode interception strategies with maximal capture zone
240
History-dependent phase slips and rectification of a few coupled oscillators system
241
History-sensitive versus future-sensitive approaches to security in distributed systems
242
History-taking and Preventive Medicine Skills among Primary Care Physicians: An Assessment Using Standardized Patients
243
Histpathological Anti-inflammatory Effects of Flunixin Meglumine and Ketoprofen on Excised Rat Tendon
244
His–Trp cation–π interaction and its structural role in an α-helical dimer of HIV-1 Vpr protein Original Research Article
245
Hit and target models for DNA damage with indirect action
246
Hit covariance formalism for stereo detectors
247
Hit covariance formalism for stereo detectors
248
Hit diabetes hard and early for best long-term results
249
Hit efficiency study of CMS prototype forward pixel detectors
250
Hit efficiency study of CMS prototype forward pixel detectors
251
Hit ʹEm Where They Live: Targeting the Cancer Stem Cell Niche
252
Hit generation and exploration: Imidazo[4,5-b]pyridine derivatives as inhibitors of Aurora kinases
253
Hit harder than HAART
254
Hit HIV-1 hard, but only when necessary Review Article
255
HIT in VAD Patients: Considerations
256
HIT NOISE REDUCTION IN SOME X-RAY IMAGES
257
Hit or miss: branch structure affects perch choice, behaviour, distance and accuracy of brown tree snakes bridging gaps
258
Hit statistics in FH-CDMA unslotted packet networks
259
Hitachi Hemolytic Index correlates with HBOC-201 concentrations: Impact on suppression of analyte results
260
Hitch in implementing Russiaʹs HIV-prevention law
261
Hitch in US product-liability reform for pharmaceuticals
262
Hitches in implementing organ-donation law in Poland
263
Hitchhikers on the fungal highway: The helper effect for bacterial migration via fungal hyphae
264
Hitchhikers on the fungal highway: The helper effect for bacterial migration via fungal hyphae
265
Hitchhiking without Covalent Integration
266
Hitching a ride on a hermit crabs home: Movement of gastropod shells inhabited by hermit crabs
267
Hitchin–Thorpe inequality for noncompact Einstein 4-manifolds
268
Hi-Tech Authentication for Palette Images Using Digital Signature and Data Hiding
269
Hi-tech breast-cancer screening: will it deliver?
270
hITeQ: A new workflow-based computing environment for streamlining discovery. Application in materials science
271
HIT-IIP: an information integrating platform for CIM system based on client/server architecture
272
Hitler, the Germans, and the Final Solution. By Ian Kershaw. New Haven, CT, and London: Yale University Press. 2008.
273
Hitler’s Ethic: The Nazi Pursuit of Evolutionary Progress. By Richard Weikart. New York: Palgrave Macmillan. 2009
274
Hitler’s Generals on Trial: The Last War Crimes Tribunal at Nuremberg. By Valerie Geneviève Hébert. Lawrence, KS: University Press of Kansas. 2010
275
Hitler’s Man in Havana: Heinz Lu¨ning and Nazi Espionage in Latin America. By Thomas D. Schoonover. With a Foreword by Louis A. Perez, Jr. Lexington, KY: University of Kentucky Press. 2008.
276
Hitlers Judenhass. Klischee und Wirklichkeit. By Ralf Georg Reuth. Munich: Piper Verlag. 2009
277
Hitologic and clinical evaluation of combined eyelid erbium:YAG and CO2 laer reurfacing
278
Hitologic Correlation of In Vivo Optical Coherence Tomography Image of the Human Retina
279
Hitologic parameter helpful to recognize teroid-treated temporal arteriti: An analyi of thirty-five cae
280
Hitologic tudy of retiniti pigmentoa due to a mutation in the RP13 gene (PRPC8): comparion with rhodopin Pro23Hi, Cy110Arg, and Glu181Ly
281
Hitology of the vitreoretinal interface after taining of the internal limiting membrane uing glucoe 5% diluted indocyanine and infracyanine green
282
Hitopathologic analyi of 232 eye with retinoblatoma conducted in an Indian tertiary-care ophthalmic center
283
Hitopathologic and immunohitochemical tudy of dominant cone degeneration
284
Hitopathologic and Immunologic Apect of AlphaCor Artificial Corneal Failure Original Reearch Article
285
Hitopathologic characteritic of uveal melanoma in eye enucleated from the collaborative ocular melanoma tudy COM report no. 6 Original Reearch Article
286
Hitopathologic Examination of Conjunctival Tophi in Gouty Arthriti
287
Hitopathologic Finding After Radial Optic Neurotomy in Central Retinal Vein Occluion
288
Hitopathologic tudy of variation in everity of retiniti pigmentoa due to the dominant rhodopin mutation Pro23Hi
289
Hitopathologic tudy of X-linked cone-rod dytrophy (CORDX1) caued by a mutation in the RPGR exon ORF15
290
Hitopathological abnormalitie in ocular blood veel of CADAIL patient
291
Hitopathology of Blepharoptoi Induced by Prolonged Hard Contact Len Wear
292
Hitopathology of the eye in diffue neonatal hemangiomatoi
293
Hitoshi Oshitani: watching out for an influenza pandemic
294
Hitoshi Sakai (1930–2008)
295
Hitox titanium pigment prices raised
296
Hitox titanium pigment prices raised for the second time this year
297
Hits and flops dynamics
298
Hits and misses: crafting a pop single for the top-40 market in the 1960s
299
Hits-and-misses for the evaluation and combination of forecasts
300
Hitting a Nerve: Ion Channels May Hold the Key for Treating Chronic Pain
301
Hitting and returning to rare events for all alpha-mixing processes
302
Hitting from any direction in 3-D space by a robot with a flexible link hammer
303
Hitting H pylori for four
304
Hitting HIV where it hurts: an alternative approach to HIV vaccine design
305
Hitting moving targets: Co-operative control of ‘when’ and ‘where’
306
Hitting of a line or a half-line in the plane by two-dimensional symmetric stable Lévy processes
307
Hitting probabilities and hitting times for stochastic fluid flows
308
HITTING PROBABILITIES AND HITTING TIMES FOR STOCHASTIC FLUID FLOWS THE BOUNDED MODEL
309
Hitting probabilities for non-convex lattice
310
Hitting sets when the VC-dimension is small
311
Hitting Spheres with Brownian Motion and Sommerfeld′s Radiation Condition
312
Hitting the distributed computing sweet spot with Tspaces
313
Hitting the mark or falling short with nanotechnology regulation? Original Research Article
314
Hitting the Target with Bifunctional Phage Review Article
315
Hitting time analysis for a class of random packet forwarding schemes in ad hoc networks
316
Hitting time distributions in financial markets
317
Hitting times for the perturbed reflecting random walk
318
Hitting times of Brownian motion and the Matsumoto–Yor property on trees
319
Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors
320
Hit-to-lead studies on benzimidazole inhibitors of ITK: Discovery of a novel class of kinase inhibitors
321
Hit-to-Lead studies: The discovery of potent adamantane amide P2X7 receptor antagonists
322
Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors
323
Hit-to-Lead studies: The discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists
324
Hit-to-Lead studies: The discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists
325
Hitungan dalam Naskhah Melayu dan Jawa: Analisis dalam Syair Laksana Kita Mujarabat
326
HIV / AIDS health literacy and Its Related Factors: a cross-sectional study
327
HIV “escape” mutants could thwart vaccine development
328
HIV A clever hijacker of the immune system
329
HIV and AIDS among the Severely Mentally Ill: Introduction to the special series
330
HIV and AIDS in southeast Asia
331
HIV and AIDS, poverty, and causation
332
HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action
333
HIV and autoimmunity
334
HIV and bone disease
335
HIV and cancer of the cervix
336
HIV and Cardiovascular Disease in Sub-Saharan Africa: The Sutton Law as Applied to Global Health
337
HIV and communication
338
HIV and complement: hijacking an immune defense
339
HIV and Coronary Heart Disease: Time for a Better Understanding
340
HIV and depression: context and care: Francisco J. Gonzales; UCSF AIDS Health Project, San Francisco, 2001, 106pp, $11.95 (paper)
341
HIV and diarrhea in the era of HAART: 1998 New York State hospitalizations
342
HIV and exclusive breastfeeding: Just how exclusive and when to stop?
343
HIV and gynaecological infections
344
HIV and hepatitis C virus RNA in seronegative organ and tissue donors
345
HIV and human rights in refugee settings
346
HIV and intimate partner violence among methadone-maintained women in New York City
347
HIV and Islam: is HIV prevalence lower among Muslims?
348
HIV and orientation of subsistence and commercial home gardens in rural Ghana: Crop composition, crop diversity and food security
349
HIV and peacekeeping operations in Cambodia
350
HIV and primary health care: disclosure and discrimination
351
HIV and sexual health in the UK: politics and public health
352
HIV and Sub-Saharan African Women in the COVID-19 Era and beyond
353
HIV and the blood supply: An analysis of crisis decisionmaking : Edited by Lauren B. Leveton, Harold C. Sox Jr, and Michael A. Stoto. Institute of Medicine, National Academy Press, Washington, DC, 1995. 352 pp., $47.95 (cloth)
354
HIV and the cell cycle
355
HIV and the paediatrician as the childʹs advocate
356
HIV and tuberculosis in the former Soviet Union
357
HIV as the cause of AIDS
358
HIV care provider perceptions and approaches to managing unhealthy alcohol use in primary HIV care settings: a qualitative study
359
HIV case shocks USA
360
HIV causes AIDS: Kochʹs postulates fulfilled
361
HIV clearance in infants
362
HIV co-infection with a currently non-pathogenic flagellate
363
HIV co-infection with tuberculous and non-tuberculous mycobacteria in western Kenya: challenges in the diagnosis and management
364
HIV control in Cuba
365
HIV control in vivo: Dynamical analysis
366
HIV controllers: A multifactorial phenotype of spontaneous viral suppression
367
HIV co-receptor identification: good or bad news for drug discovery?
368
HIV Coreceptor Usage and Drug Treatment
369
HIV could blunt progress in China, Clinton warns
370
HIV disclosure and discussions about grief with Shona children: A comparison between health care workers and community members in Eastern Zimbabwe
371
HIV Disclosure by Perinatal Women in Thailand
372
HIV discoverers awarded Nobel Prize for medicine
373
HIV Disease
374
HIV disease in the year 2000
375
HIV disease progression and effects of tuberculosis preventive therapy in HIV-infected adults
376
HIV disease progression: depression, stress, and possible mechanisms
377
HIV disease treatment in the era of HAART
378
HIV disease: mucocutaneous fungal infections in HIV disease
379
HIV drug resistance among naïve HIV-infected patients in Iran
380
HIV dynamics: Analysis and robust multirate MPC-based treatment schedules
381
HIV dynamics: Modeling, data analysis, and optimal treatment protocols
382
HIV education for health-care professionals in high prevalence countries: time to integrate a pre-service approach into training
383
HIV education in emergency, conflict, and post-conflict contexts
384
HIV education in the formal curriculum
385
HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes
386
HIV entry inhibitors
387
HIV Entry Revisited
388
HIV Envelope-CXCR4 Signaling Activates Cofilin to Overcome Cortical Actin Restriction in Resting CD4 T Cells
389
HIV epidemic could number 40 million by year 2000
390
HIV epidemic in Central India: trends over 18 years (1986–2003)
391
HIV epidemic in India
392
HIV epidemic in India: opportunity to learn from the past
393
HIV epidemic in Russia
394
HIV escape from cytotoxic T lymphocytes: a potential hurdle for vaccines?
395
HIV Fusion Peptide Penetrates, Disorders, and Softens T-Cell Membrane Mimics
396
HIV Gag p24 specific responses secreting IFN-γ and/or IL-2 in treatment-naïve individuals in acute infection early disease (AIED) are associated with low viral load
397
HIV gene arrests cell cycle
398
HIV Genetic effects on immunity Immunity to infection Web alert
399
HIV GOVERNANCE THROUGH LAW: ACHIEVEMENTS AND CHALLENGES OF CHINA S LEGAL ENVIRONMENT
400
HIV gp120 V1/V2 and C2-V3 domains glycoprotein compatibility is required for viral replication
401
HIV gp120: double lock strategy foils host defences
402
HIV Health Literacy (HALTRA) Model: A New Model Based on Information and Motivation to Eradicate Social Stigma
403
HIV in central and eastern Europe
404
HIV in England and Wales
405
HIV in Pakistan: An emerging menace
406
HIV in the over-50s in south London
407
HIV incidence among injecting drug users in New York City syringe-exchange programmes
408
HIV Incidence and CDC’s HIV Prevention Budget: An Exploratory Correlational Analysis
409
HIV Indeterminate Western Blot Results in Blood Donors in Northeast of Iran, 2009-2014
410
HIV Infected Young Man with Prolonged Fever and Cough
411
HIV infection and advanced age: Emerging epidemiological, clinical, and management issues
412
HIV infection and chronic hepatitis C
413
HIV infection and high density lipoprotein metabolism
414
HIV infection and high-risk behaviors in opioid dependent patients: The Indian context
415
HIV infection and neoplasia
416
HIV infection and neoplasia
417
HIV infection and neoplasia
418
HIV infection and neoplasia
419
HIV infection and neoplasia
420
HIV infection and related risk behaviours among female sex workers in greater Cairo, Egypt
421
HIV infection and sex in sex-on-premises venues are associated with a higher risk of syphilis reinfection among men who have sex with men
422
HIV Infection and the Dynamic Interplay between the Thymus and the Peripheral T Cell Pool
423
HIV infection from donor semen
424
HIV infection in Cuban women
425
HIV Infection in Iran: An Update on Epidemiology, Testing and Gaps
426
HIV infection of CD8 cells
427
Hiv infection of endothelial cells promotes the development of aids-associated b cell lymphomas
428
HIV infection of mononuclear cells is calcium-dependent
429
HIV infection rates in Japan projected to increase
430
HIV infection reduces skin graft survival in burn injuries: a prospective study
431
HIV Infection, HIV/HCV and HIV/HBV co-infections among Jail Inmates of Lahore
432
HIV infection: first battle decides the war
433
HIV infection: where have all the T cells gone?
434
HIV interaction with endosomes in macrophages and dendritic cells
435
HIV levels in motherʹs blood predicts risk of perinatal transmission
436
HIV levels may predict mother-to-child
437
HIV may produce inhibitory microRNAs (miRNAs) that block production of CD28, CD4 and some interleukins
438
HIV Modes of Transmission in Sudan in 2014
439
HIV myths should not be resuscitated
440
HIV myths should not be resuscitated
441
HIV myths should not be resuscitated – Authorʹs reply
442
HIV nucleoside analogues: new adverse effects on mitochondria?
443
HIV outreach for hard-to-reach populations: a cross-site perspective
444
HIV overshadows South African health advances
445
HIV p17 reverses the anti-inflammatory activity of IL-4 on IL-15 stimulated monocytes and modulates their ability to secrete MIP-1 alpha
446
HIV Patients’ Satisfaction with Services Provided at Tertiary Health Institutions in Ogun East Senatorial District, Ogun State, Nigeria: Public-private Comparison
447
HIV positive women's living experiences
448
HIV postexposure prophylaxis for children and adolescents
449
HIV postexposure prophylaxis in the emergency department: The morning after is today
450
HIV Postexposure Prophylaxis in Victims of Child Sexual Abuse
451
HIV postexposure prophylaxis practices by US ED practitioners
452
HIV Preparing for HIV vaccines that induce cytotoxic T lymphocytes
453
HIV prevalence among men who have sex with men in Iran: A systematic review and meta-analys s
454
HIV Prevalence among Pregnant Women in Eight Provincial Capitals in Indonesia in 2003-2010.
455
HIV prevalence among pregnant women in Kigali, Rwanda
456
HIV prevalence and poverty in Africa: Micro- and macro-econometric evidences applied to Burkina Faso
457
HIV Prevalence and Risk Behaviors among Patients Attending Los Angeles County Tuberculosis Clinics: 1993–1996
458
HIV prevalence and trends in sub-Saharan Africa: no decline and large subregional differences
459
HIV prevention among Zambian adolescents: Developing a value utilization/norm change model
460
HIV prevention and treatment in South Africa: affordable and desirable
461
HIV prevention before HAART in sub-Saharan Africa
462
HIV prevention efforts reach fewer than one in five at risk
463
HIV prevention for intravenous drug users
464
HIV prevention in developed countrie
465
HIV prevention perception among barbers according to health belief model
466
HIV prevention research in a resource-limited setting: the experience of planning a trial in Cambodia
467
HIV prevention research: the ecstasy and the agony
468
HIV prevention, childrens rights, and homosexual youth
469
HIV programme for aid workers in Norway
470
HIV Programs in Iran (Persia), Iraq and Saudi Arabia: A Brief Review of Current Evidence in West and Southwest Asia
471
HIV Prophylaxis in High Risk Newborns: An Examination of Sociodemographic Factors in an Inner City Context
472
HIV protease inhibitor HOE/BAY 793, structure-activity relationships in a series of C2-symmetric diols Original Research Article
473
HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathway
474
HIV protease inhibitors block oral epithelial cell DNA synthesis
475
HIV protease inhibitors have specific anti-cancer effects
476
HIV protease inhibitors increase TNF-α and IL-6 expression in macrophages: Involvement of the RNA-binding protein HuR
477
HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituent
478
HIV quantification: clinical applications
479
HIV quantification: useful for prediction of vertical transmission?
480
HIV Rapid Diagnostic Test Inventories in Zambézia Province, Mozambique: A Tale of 2 Test Kits
481
HIV Recent advances in AIDS research: genetics, molecular biology and immunology
482
HIV research: a need to focus on the right target
483
HIV Responses in Arab States on the Southern Persian Gulf Border: The First Review
484
HIV Rev self-assembly is linked to a molten-globule to compact structural transition Original Research Article
485
HIV risk behavior among adults with severe mental illness: A systematic review
486
Hiv risk behavior among alcoholic inpatients before and after treatment
487
HIV risk environment for Ghanaian women: challenges to prevention
488
HIV risk networks and HIV transmission among injecting drug users
489
HIV risk perception and sexual behaviors among female sex workers in Tehran, Iran
490
HIV risk reduction among injection drug users: explaining the lack of anticipated outcomes in a community-level controlled comparison study
491
HIV risk reduction for the seriously mentally ill: Pilot investigation and call for research
492
HIV risk reduction interventions for persons with severe mental illness
493
HIV risk-reduction in adolescents
494
HIV risks among homeless men differentiated by cocaine use and psychiatric distress
495
HIV risks in incarcerated injection-drug users
496
HIV screening of blood transfusions in Zambia
497
HIV self-testing: a time to revise current policy
498
HIV SEROPOSITIVITY IN CHILDREN WITH SICKLE CELL DISEASE
499
HIV Seroprevalence among Newly Incarcerated Inmates in the Texas Correctional System
500
HIV seroprevalence among people with severe mental illness in the United States: A critical review
501
HIV seroprevalence by anonymous testing in patients with Mycobacterium tuberculosis and in tuberculosis contacts
502
HIV serostatus and factors related to physical and mental well-being in Latina family AIDS caregivers
503
HIV status disclosure and partner discordance: A public health dilemma
504
HIV Stigma among People Living with HIV in Southeast Iran
505
HIV stigma: perceptions from HIV-positive and HIV-negative patients in a community dental clinic
506
HIV strategically targets HIV-specific T cells
507
HIV superinfection: another reason to avoid serosorting practice
508
HIV test results, partner notification, and personal conduct
509
HIV Testing among Men Who Have Sex with Men—Results of a Telephone Survey
510
HIV testing and human rights
511
HIV testing history among gay/bisexual men recruited in Barcelona: Evidence of high levels of risk behavior among self-reported HIV+ men
512
HIV testing in developing countries
513
HIV testing in prison
514
HIV Testing in the Emergency Department: Pretest Counseling or Pretest Education?
515
HIV testing over Easter
516
HIV testing: Should the emergency department take part?
517
HIV testing: the mutual rights and responsibilities of partners
518
HIV tests for babies to be mandatory in USA
519
HIV The immune response
520
HIV time hierarchy: winning the war while, loosing all the battles
521
HIV transmission by donor semen
522
HIV transmission by transplantation of allograft skin: a review of the literature
523
HIV transmission from surrogate breastfeeding
524
HIV transmission through health care in sub-Saharan Africa
525
HIV transmission through health care in sub-Saharan Africa
526
HIV transmission through health care in sub-Saharan Africa
527
HIV transmission under highly active antiretroviral therapy
528
HIV transmission under highly active antiretroviral therapy – Authorsʹ reply
529
HIV treatment cascade among female entertainment and sex workers in Cambodia: impact of amphetamine use and an HIV prevention program
530
HIV treatment in South Africa: overcoming impediments to get started
531
HIV treatment in South African children
532
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis
533
HIV treatment, injection drug use, and illicit drug policies
534
HIV vaccine fails in phase 3 trial
535
HIV vaccine: how long must we wait?
536
HIV vaccine: how long must we wait?
537
HIV vaccines: where we are and where we are going
538
HIV voluntary counselling and testing in community health services
539
HIV, confidentiality, gender, and support in rural South Africa
540
HIV, EBV and KSHV: Viral cooperation in the pathogenesis of human malignancies
541
HIV, fatal rotavirus infection, and treatment options
542
HIV, fatal rotavirus infection, and treatment options
543
HIV, Hepatitis B and Hepatitis C in garbage scavengers of Karachi
544
HIV, occupational exposure, and medical responsibilities
545
HIV/AIDS Among Injecting Drug Users: A review on Epidemiology and Management of Occupational Exposure in Iranian Health Network Setting
546
HIV/AIDS and access to water: A case study of home-based care in Ngamiland, Botswana
547
HIV/AIDS and community conflict in Nigeria: implications and challenges
548
HIV/AIDS and Education: a study on how a selection of school governing bodies in Mpumalanga understand, respond to and implement legislation and policies on HIV/AIDS
549
HIV/AIDS and Farms’ Production Efficiency in Benue State, Nigeria
550
HIV/AIDS and human rights
551
HIV/AIDS and its impact on student nurses
552
HIV/AIDS and people with disability
553
HIV/AIDS AND SHIFTING URBAN CHINA S SOCIOMORAL LANDSCAPE: ENGENDERING BIO-ACTIVISM AND RESISTANCE THROUGH STORIES OF SUFFERING
554
HIV/AIDS and the construction of Sub-Saharan Africa: Heuristic lessons from the social sciences for policy
555
HIV/AIDS AND WELL-BEING IN SOUTH CENTRAL AND SOUTH-EAST ASIA
556
HIV/AIDS Awareness Study of Fresh Students in Tertiary Institutions in Rivers State of Nigeria
557
HIV/AIDS cases in 1999 set to keep increasing into the next century
558
HIV/AIDS conference highlights Lesothoʹs progress
559
HIV/AIDS control in India
560
HIV/AIDS Counseling Skills and Strategies: Can Testing and Counseling Curb the Epidemic?
561
HIV/AIDS data in South Africa
562
HIV/AIDS data in South Africa
563
HIV/AIDS Disease: Transmission Transition
564
HIV/AIDS dynamics: Impact of economic classes with transmission from poor clinical settings
565
HIV/AIDS education among incarcerated youth
566
HIV/AIDS epidemic features and trends in Saudi Arabia
567
HIV/AIDS epidemiology
568
HIV/AIDS epidemiology, pathogenesis, prevention, and treatment
569
HIV/AIDS estimates and the quest for universal access
570
HIV/AIDS explosion in Russia triggers research boom
571
HIV/AIDS Good News and Bad News
572
HIV/AIDS harm reduction in Iran
573
HIV/AIDS High Risk Behaviors and Necessity of Prevention in the Population of Birjand, East of Iran 2013 to 2014: A Population-Based Study
574
HIV/AIDS High Risk Behaviors and Necessity of Prevention in the Population of Birjand, East of Iran 2013 to 2014: A Population-Based Study
575
HIV/AIDS in Africa
576
HIV/AIDS IN AFRICA IN CONTEXT
577
HIV/AIDS in Africa, 2002
578
HIV/AIDS in Asia
579
HIV/AIDS in children: a disaster in the making
580
HIV/AIDS in China: the numbers problem
581
HIV/AIDS in our Midst and Minds
582
HIV/AIDS in South Africa
583
HIV/AIDS in the last 10 years
584
HIV/AIDS IN XINJIANG: A SERIOUS ILL IN AN AUTONOMOUS REGION
585
HIV/AIDS infection control enforcement: a comparison between Nigeria and the United States
586
HIV/AIDS Information Awareness among Market Women: A Study of Olofimuyin Market, Sango-Ota, Ogun State, Nigeria
587
HIV/AIDS information outreach: a community-based approach
588
HIV/AIDS information overload
589
HIV/AIDS institutional discrimination in Switzerland
590
HIV/AIDS issues take centre-stage at World Health Assembly
591
HIV/AIDS knowledge among undergraduate university students: implications for health education programs in Ghana
592
HIV/AIDS Knowledge and Attitude among High School Students in Shiraz, Iran in 2015
593
HIV/AIDS Knowledge and attitudes of Southern Iranian students
594
HIV/AIDS knowledge, attitudes and beliefs among a group of Iraqis
595
HIV/AIDS lowers UNʹs global population estimates
596
HIV/AIDS Monitoring and Evaluation Systems Strengthening for the National AIDS Program in Albania
597
HIV/AIDS policy agenda setting in Iran
598
HIV/AIDS prevention and treatment
599
HIV/AIDS prevention and treatment
600
HIV/AIDS prevention and treatment
601
HIV/AIDS prevention and treatment
602
HIV/AIDS prevention and treatment
603
HIV/AIDS prevention and treatment
604
HIV/AIDS Prevention Factors from Contagious Risk Behavior Among Middle School Students
605
HIV/AIDS prevention for migrants and ethnic minorities: three phases of evaluation
606
HIV/AIDS Preventive Education amongst Biology Teachers: Assessing Knowledge and Attitudinal Change
607
HIV/AIDS Related Stigma in Iran: A Qualitative Study
608
HIV/AIDS research in India: A bibliometric study
609
HIV/AIDS Risk Behaviours Among Injecting Drug Users: Addressing Development of Risk Behaviour Knowledge and Patterns of Risk Behaviour Practices in Context of Demographic Characteristics
610
HIV/AIDS Situation in Economic Cooperation Countries; Achievement and Gaps toward Millennium Development Goals
611
HIV/AIDS surveillance in Egypt: current status and future challenges
612
HIV/AIDS treatment and HIV vaccines for Africa
613
HIV/AIDS vulnerability of Nepali migrants to India: whose concern?
614
HIV/AIDS, artisanal fishing and food security in the Okavango Delta, Botswana
615
HIV/AIDS, gender, agency and empowerment issues in Africa
616
HIV/AIDS, human capital, and economic growth prospects for Mozambique
617
HIV/AIDS. A Guide to Nursing Care, 3rd edn., J.H. Flaskerud, P. Unguarski. W B Saunders, Switzerland (1995), ISBN: 0 7216 5239 5
618
HIV/AIDS: A Cross-cutting Theme in Human Rights –Domestic and International Dimensions
619
HIV/AIDS: Global Frontiers in Prevention/Intervention, C. Pope, R.T. White, R. Malow (Eds.). Routledge, New York (2008). 572 p., paperback US$49.95, ISBN: 978-0-415-95383-2.
620
HIV/AIDS: in search of an animal model Original Research Article
621
HIV/AIDS: the private sector is vital
622
HIV/AIDS—An issuein nurse education
623
HIV/AIDS-Associated Stigma Among Afro-Caribbean People Living in the United States
624
HIV/AIDS—call for papers
625
HIV/AIDS—call for papers
626
HIV/AIDS-related social anxieties in adolescents in three African countries
627
HIV/AIDS-related stigma and discrimination: Accounts of HIV-positive Caribbean people in the United Kingdom
628
HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article
629
HIV/HCV coinfection, HAART, and liver-related mortality
630
HIV/HCV coinfection, HAART, and liver-related mortality
631
HIV/STD-Protective Benefits of Living with Mothers in Perceived Supportive Families: A Study of High-Risk African American Female Teens
632
HIV: An Epidemiologic study on Head and Neck Involvement in 50 Patients
633
HIV: Immunity to infection. Genetic effects on immunity: Web alert
634
HIV: Medical Milestones and Clinical Challenges
635
HIV: Pre-exposure Prophylaxis
636
HIV: T cell responses to HIV: Editorial overview
637
HIV: the other dimension
638
HIV: Ufff…I Got a Needle Prick
639
HIV-1 and AIDS awareness in a marginalised Namibian community
640
HIV-1 and hepatitis B virus: time for a re-think?
641
HIV-1 and immune control: can we change the course of HIV-1?
642
HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers
643
HIV-1 and scrub-typhus
644
HIV-1 and tuberculosis infection
645
HIV-1 and tuberculosis infection
646
HIV-1 at 25
647
HIV-1 biological phenotype and predicted coreceptor usage based on V3 loop sequence in paired PBMC and plasma samples
648
HIV-1 care in resource-poor settings: a view from Haiti
649
HIV-1 Coreceptor Selectivity: Structural Analogy between HIV-1 V3 Regions and Chemokine β-Hairpins Is Not the Explanation
650
HIV-1 disease progression and AIDS-defining disorders in rural Uganda
651
HIV-1 diversity versus HLA class I polymorphism
652
HIV-1 DNA vaccine shows promise in chimpanzees
653
HIV-1 drug resistance reported in Brazil
654
HIV–1 dynamics at different time scales under antiretroviral therapy
655
HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation Review Article
656
HIV-1 fusion mechanism could be target for new drugs
657
HIV-1 Gag Extension: Conformational Changes Require Simultaneous Interaction with Membrane and Nucleic Acid
658
HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap
659
HIV-1 gp120-induced sickness behavior is exacerbated in aged mice: Is this exaggerated sickness behavior potentially mediated through a pathway involving the up-regulation of CXCR4?
660
HIV-1 group O and group M dual infection in Bénin
661
HIV-1 group O and group M dual infection in Bénin
662
HIV-1 group O infection identified in USA
663
HIV-1 group O infection in the USA
664
HIV-1 immunopathogenesis: How good interferon turns bad
665
HIV-1 in injecting-drug users and heterosexuals
666
HIV-1 in semen: an isolated virus reservoir
667
HIV-1 in Taiwan
668
HIV-1 incidence and prevalence trends in Uganda
669
HIV-1 incidence and prevalence trends in Uganda
670
HIV-1 incidence in sub-Saharan Africa
671
HIV-1 induced decrease of nitric oxide production and inducible nitric oxide synthase expression during in vivo and in vitro infection
672
HIV-1 infected patients with toxic epidermal necrolysis: an occupational risk for healthcare workers
673
HIV-1 infection and intraepithelial neoplasia of lower genital tract
674
HIV-1 infection and malaria parasitaemia
675
HIV-1 infection and malaria parasitaemia
676
HIV-1 infection and malaria parasitaemia
677
HIV-1 infection and malaria parasitaemia
678
HIV-1 infection and prostitutes
679
HIV-1 infection and risk of tuberculosis after rifampicin treatment
680
HIV-1 infection and risk of tuberculosis after rifampicin treatment
681
HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study
682
HIV-1 infection and the female genital tract
683
HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
684
HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
685
HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
686
HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis
687
HIV-1 infection by artificial insemination
688
HIV-1 infection in a man homozygous for CCR5▭∆32
689
HIV-1 infection in an individual homozygous for CCR5▭∆32
690
HIV-1 infection in China
691
HIV-1 infection in commercial plasma donors in China
692
HIV-1 infection in foreign nationals working in East Timor
693
HIV-1 Infection Induces Acetylation of NPM1 That Facilitates Tat Localization and Enhances Viral Transactivation
694
HIV-1 infection initiates changes in the expression of a wide array of genes in U937 promonocytes and HUT78 T cells
695
HIV-1 infection kinetics in tissue cultures
696
HIV-1 infection puzzles Denmark
697
HIV-1 infection rapidly alters cell gene expression
698
HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors
699
HIV-1 Integrase Strand Transfer Inhibitors Stabilize an Integrase–Single Blunt-Ended DNA Complex
700
HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots
701
HIV-1 long terminal repeat modulation by glucocorticoids in monocytic and lymphocytic cell lines
702
HIV-1 Matrix Protein Binding to RNA
703
HIV-1 matrix protein: A mysterious regulator of the viral life cycle
704
HIV-1 Nef associates with p22-phox, a component of the NADPH oxidase protein complex
705
HIV-1 Nef Dimerization Is Required for Nef-Mediated Receptor Downregulation and Viral Replication
706
HIV-1 Nef Downregulates MHC-I by a PACS-1- and PI3K-Regulated ARF6 Endocytic Pathway
707
HIV-1 nucleocapsid protein activates transient melting of least stable parts of the secondary structure of TAR and its complementary sequence
708
HIV-1 Nucleocapsid Protein as a Nucleic Acid Chaperone: Spectroscopic Study of its Helix-destabilizing Properties, Structural Binding Specificity, and Annealing Activity
709
HIV-1 Nucleocapsid Protein Binds to the Viral DNA Initiation Sequences and Chaperones their Kissing Interactions
710
HIV-1 Nucleocapsid Protein Switches the Pathway of Transactivation Response Element RNA/DNA Annealing from Loop–Loop “Kissing” to “Zipper”
711
HIV-1 nucleocapsid protein zinc finger structures induce tRNALys,3 structural changes but are not critical for primer/template annealing
712
HIV-1 p17 binds heparan sulfate proteoglycans to activated CD4+ T cells
713
HIV-1 peripheral neuropathy and combination antiretroviral therapy
714
HIV-1 prevalence in young adults in south India
715
HIV-1 prevalence in young adults in south India
716
HIV-1 prevalence in young adults in south India
717
HIV-1 prevalence in young adults in south India
718
HIV-1 prevalence in young adults in south India
719
HIV-1 prevalence in young adults in south India – Authorsʹ reply
720
HIV-1 prevention in the context of increasing access to treatment
721
HIV-1 progression in hepatitis-C-infected drug users
722
HIV-1 progression in hepatitis-C-infected drug users
723
HIV-1 progression in hepatitis-C-infected drug users
724
HIV-1 progression in hepatitis-C-infected drug users
725
HIV-1 Protease Dimer Interface Mutations that Compensate for Viral Reverse Transcriptase Instability in Infectious Virions
726
HIV-1 protease inhibitors containing an N-Hydroxyamino acid core structure Original Research Article
727
HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1′ substituent
728
HIV-1 Proteinase as Structural Model of Intercellular Transport Proteins of Plant Viruses
729
HIV-1 reactivation in HIV-latently infected dendritic cells by oral microorganisms and LPS
730
HIV-1 Replication and Latency Are Regulated by Translational Control of Cyclin T1
731
HIV-1 Replication in Monocyte-derived Dendritic Cells is Stimulated by Melarsoprol, One of the Main Drugs Against Human African Trypanosomiasis
732
HIV-1 replication in patients with undetectable plasma virus receiving HAART
733
HIV-1 replication inhibitors of the styrylquinoline class: incorporation of a masked diketo acid pharmacophore
734
HIV-1 replication inhibitors of the styrylquinoline class: introduction of an additional carboxyl group at the C-5 position of the quinoline
735
HIV-1 researchers talk cautiously of a good year
736
HIV-1 Reverse Transcriptase Can Simultaneously Engage Its DNA/RNA Substrate at Both DNA Polymerase and RNase H Active Sites: Implications for RNase H Inhibition
737
HIV-1 Reverse Transcriptase Dissociates during Strand Transfer
738
HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: A view from the clinic and ex vivo
739
HIV-1 reverse transcription initiation: A potential target for novel antivirals?
740
HIV-1 Reverse Transcription: A Brief Overview Focused on Structure–Function Relationships among Molecules Involved in Initiation of the Reaction
741
HIV-1 RNA and CD4+ counts to predict the risk of AIDS
742
HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy
743
HIV-1 Sequence Variation: Drift, Shift, and Attenuation
744
HIV-1 seroprevalence rates in women and relinquishment of infants to the state in St Petersburg, Russia, 2002
745
HIV-1 serum RNA load and resistance during early ZDV therapy
746
HIV-1 shedding in genital tract of infected women
747
HIV-1 shedding in genital tract of infected women
748
HIV-1 shedding in genital tract of infected women
749
HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication
750
HIV-1 statistics bring good news for Uganda
751
HIV-1 subtype B in Honduras
752
HIV-1 subtype B in West Africa
753
HIV-1 subtype C in China
754
HIV-1 subtypes and circulating recombinant forms (CRFs) in Northern Greece
755
HIV-1 subtypes and male-to-female transmission in Thailand
756
HIV-1 subtypes in different risk groups in South Africa
757
HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitor
758
HIV-1 suppression during acute scrub-typhus infection
759
HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathy
760
HIV-1 Tat interaction with cyclin T1 represses mannose receptor and the bone morphogenetic protein receptor-2 transcription
761
HIV-1 Tat Protects CD4+ Jurkat T Lymphoblastoid Cells from Apoptosis Mediated by TNF-Related Apoptosis-Inducing Ligand
762
HIV-1 Tat Protein and Its Inhibitor Ro 24-7429 Inhibit Lymphocyte Proliferation and Induce Apoptosis in Peripheral Blood Mononuclear Cells from Healthy Donors
763
HIV-1 Tat protein induces IL-10 production by an alternative TNF-α-independent pathway in monocytes: Role of PKC-δ and p38 MAP kinase
764
HIV-1 Tat protein induces TNF-α and IL-10 production by human macrophages: Differential implication of PKC-βII and -δ isozymes and MAP kinases ERK1/2 and p38
765
HIV-1 Tat vaccines
766
HIV-1 Tat: coping with negative elongation factors
767
HIV-1 Tat-mediated protein transduction of Cu,Zn-superoxide dismutase into pancreatic β cells in vitro and in vivo
768
HIV-1 therapy and fetal mitochondrial dysfunction
769
HIV-1 trans-Activating (Tat) Protein BOTH A TARGET AND A TOOL IN THERAPEUTIC APPROACHES
770
HIV-1 Transcription: Activation Mediated by Acetylation of Tat
771
HIV-1 transforms the monocyte plasma membrane proteome
772
HIV-1 transmission during scintigraphy
773
HIV-1 transmission through artificial insemination
774
HIV-1 transport across the blood–brain barrier is enhanced by lipopolysaccharide
775
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
776
HIV-1 vaccines and the nef story so far
777
HIV-1 viral load and scrub typhus
778
HIV-1 viral load and scrub typhus
779
HIV-1 viral load and scrub typhus
780
HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial
781
HIV-1 Viral RNA Is Selected in the Form of Monomers that Dimerize in a Three-step Protease-dependent Process; the DIS of Stem–Loop 1 Initiates Viral RNA Dimerization
782
HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific
783
HIV-1, antiretroviral therapy, and malaria
784
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
785
HIV-1, the brain, and combination therapy
786
HIV-1/AIDS and maternal and child health in Africa
787
HIV-1/AIDS and the control of other infectious diseases in Africa
788
HIV-1/HIV-2 co-infection among voluntary counselling and testing subjects at a regional hospital in Cameroon
789
HIV-1: hitching a ride on erythrocytes
790
HIV-1-associated nephropathy and response to highly-active antiretroviral therapy
791
HIV-1c vaccine trial planned for South Africa
792
HIV-1-mediated syncytium formation promotes cell-to-cell transfer of Tax protein and HTLV-I gene expression
793
HIV-1-resistance mechanisms continue to unravel
794
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
795
HIV-1-resistant individuals may lack HIV-1 coreceptor
796
HIV-1-vaccine-trial go-ahead reawakens ethics debate
797
HIV-2 and T cell recognition
798
HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy
799
HIV-associated cardiovascular complications: a new challenge for emergency physicians
800
HIV-associated diarrhoea and wasting
801
HIV-associated diarrhoea and wasting : Report of a meeting at the University of Texas Medical School at Houston
802
HIV-associated immune complex glomerulonephritis with lupus-like features
803
HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation
804
HIV-Associated Nephropathy in the Era of Antiretroviral Therapy
805
HIV-associated neurosyphilis: Report of a fatal case due to fear of work-place stigma
806
HIV-associated respiratory disease
807
HIV-associated respiratory disease
808
HIV-associated respiratory disease
809
HIV-associated respiratory diseases
810
HIV-contamination scare adds to US gene researchersʹ woes
811
HIV-Derived Lentiviral Vectors: Current Progress toward Gene Therapy and DNA Vaccination
812
Hive: distributed agents for networking things
813
HIVE: Helping Interdisciplinary Vocabulary Engineering
814
HIV-Encephalopathy as initial manifestation of acquired immunodeficiency Syndrome in Yucatلn State, Mexico
815
HIV-I TAT Inhibits PKR Activity by Both RNA-Dependent and RNA-Independent Mechanisms
816
HIV-Induced Syncytia in Peripheral Blood Cell Cultures Crawl by Extending Giant Pseudopods
817
HIV-infected healthcare workers: results from a straw poll
818
HIV-infected women in ART programmes
819
HIV-infected women: Barriers to AZT use
820
HIV-integrase aptamer folds into a parallel quadruplex: A thermodynamic study Original Research Article
821
HIV-l and the microRNA-guided silencing pathway: An intricate and multifaceted encounter
822
HIV-negative patient with HHV-8 DNA follicular B-cell lymphoma associated with Kaposiʹs sarcoma
823
HIVNET nevirapine trials
824
HIVNET nevirapine trials
825
HIVNET nevirapine trials
826
HIVNET nevirapine trials
827
HIVNET nevirapine trials
828
HivNet: Studying in Depth the Morphology of HIV-1 Virion Using Deep Learning
829
HIV-positive mothers in Uganda resort to breastfeeding
830
HIV-Positive Patients: Dental Management Considerations
831
HIV-positive people, risk and sexual behaviour
832
HIV-positive servicemen in USA face discharge
833
HIV-prevention strategies
834
HIV-prevention strategies
835
HIV-related knowledge and AIDS stigma among college students in Yemen
836
HIV-Related Knowledge and Stigma Among the General Population in the Southeast of Iran
837
HIV-related lipodystrophy and facial lipoatrophy: The role of Restylane SubQ in reversing facial wasting
838
HIV-related lipodystrophy and related factors
839
HIV-related oral disease
840
HIV-Related Oral Lesions, Demographic Factors, Clinical Staging and Anti-Retroviral Use
841
HIV-related sexual behaviour among migrants and non-migrants in a rural area of China: Role of rural-to-urban migration
842
HIV-related sexual risk assessment among Asian/Pacific Islander American Women: an inductive model
843
HIV-related skin diseases
844
HIV-related skin diseases
845
HIV-related skin diseases
846
HIV-related skin diseases
847
HIV-Related Stigma Among Healthcare Providers in Different Healthcare Settings: A Cross-Sectional Study in Kerman, Iran
848
HIV-related stigma and discrimination: a study of health care workers in Banda Aceh, Indonesia
849
HIV-related stigma: Adapting a theoretical framework for use in India
850
HIV-related thrombocytopenia
851
HIV-specific CD4+ T cells and viremia: whoʹs in control?
852
HIV-specific immunity in HIV-discordant heterosexual couples
853
HIV-vaccine research takes one step forward … and one step back
854
HIWI2 rs508485 Polymorphism Is Associated with Non-obstructive Azoospermia in Iranian Patients
855
HIx concentration by electro-electrodialysis using stacked cells for thermochemical water-splitting IS process
856
HIx system thermodynamic model for hydrogen production by the Sulfur–Iodine cycle
857
Hiyama coupling reaction of fluorous alkenyl-fluorosilanes: Scope and mechanistic considerations
858
Hiyama reaction of aryl bromides with arylsiloxanes catalyzed by a reusable palladium(II)/cationic bipyridyl system in water
859
HJA (1921–2008)
860
Hjálmar Vilhjálmsson (September 25, 1937–August 20, 2011)
861
Hjelmslev planes over nearrings Original Research Article
862
Hjørlandʹs critique of batesʹ work on defining information
863
Hjrat aur Pakistan Mein Doosray Sheher
864
HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres
865
HJWFTAC: software for Hantush–Jacob analysis of variable-rate, multiple-extraction well pumping tests
866
HK97 Maturation Studied by Crystallography and H/2H Exchange Reveals the Structural Basis for Exothermic Particle Transitions
867
H-kernels by walks in subdivision digraph
868
HKR theorem for smooth S-algebras
869
HKT and OKT geometries on soliton black hole moduli spaces Original Research Article
870
HKT geometry and de Sitter supergravity Original Research Article
871
HKUST-1 as an efficient and reusable heterogeneous catalyst for synthesis of 1,4-dihydropyridine at room temperature
872
HL 752: A potent and long-acting antispasmodic agent Original Research Article
873
HL Aurigae: A pre-contact binary system with a solar-mass companion
874
H–L curve: A novel 2D graphical representation for DNA sequences
875
HL-2A control system and its discharge management
876
HL-60 cells degrade α-actinin to produce a fragment that promotes monocyte/macrophage maturation
877
HL7 Messaging Engine with Customizable Translation System
878
HLA and AIDS: a cautionary tale
879
HLA and autoimmune diseases: Type 1 diabetes (T1D) as an example
880
HLA and inflammatory bowel disease
881
HLA and KIR polymorphisms affect NK-cell anti-tumor activity
882
HLA and natural history of HIV infection
883
HLA AND RISK OF ACUTE GRAFT VERSUS HOST DISEASE IN ALLOGENEIC BONE MARROW TRANSPLANTATION FROM AN HLA-IDENTICAL SIBLING
884
HLA antigen frequencies in end-stage idiopathic and ischaemic cardiomyopathy
885
HLA antigens and inflammatory bowel disease in a sample of Iraqi patients
886
HLA antigens in an Omani population with dilated cardiomyopathy
887
HLA antigens in patients with interferon-α-induced autoimmune thyroid disorders in chronic hepatitis C
888
HLA antigens in patients with variant angina in Japan
889
HLA antigens in schizophrenia and mood disorders
890
HLA association with autoimmune disease: restricted binding or T-cell selection?
891
HLA associations in type 1 diabetes: merging genetics and immunology
892
HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia)
893
HLA based architecture for molecular communication simulation
894
HLA Class I Allele Frequencies in Southern Iranian Women with Breast Cancer
895
HLA Class I and Class II Genes Distribution of the Sistanis in Iran
896
HLA class I and II antigens expression in patients with renal cell carcinoma
897
HLA class I and II polymorphisms in Mexican Mestizo patients with dengue fever
898
HLA class I antigen expression in malignant cells: why does it not always correlate with CTL-mediated lysis?
899
HLA Class I Expression on Human Ovarian Carcinoma Cells Correlates with T-Cell Infiltrationin Vivoand T-Cell Expansionin Vitroin Low Concentrations of Recombinant Interleukin-2
900
HLA Class I Gene Polymorphism in Iranian Patients with Papillon-Lefevre Syndrome
901
HLA class I specific inhibitory receptors
902
HLA class I, II & III genes in confirmed late-onset Alzheimer’s disease
903
HLA Class II Allele and Haplotype Frequencies in Iranian Patients with Acute Myelogenous Leukemia and Control Group
904
HLA Class II Allele and Haplotype Frequencies in Iranian Patients with Leukemia
905
HLA class II alleles and genetic predisposition to the antiphospholipid syndrome
906
HLA class II and antibody responses to circumsporozoite protein repeats of P. vivax (VK210, VK247 and P. vivax-like) in individuals naturally exposed to malaria
907
HLA class II and autoimmunity: Epitope selection vs differential expression
908
HLA class II association with autoimmune hepatitis in Latin America: A meta-analysis
909
HLA class II DNA typing in Buergerʹs disease
910
HLA class II favors clearance of HCV infection and progression of the chronic liver damage
911
HLA class II Genetic Diversity in Arabs and Jews of Iran
912
HLA class II genotype, HLA-DR B cell surface expression and allergen specific IgE production in atopic and non-atopic members of asthmatic family pedigrees
913
HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID)
914
HLA Class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis
915
HLA class II involvement in HIV-associated Toxoplasmic encephalitis development
916
HLA Class II Molecule Signal Transduction Leads to either Apoptosis or Activation via Two Different Pathways
917
HLA class II polymorphism in Latin American patients with multiple sclerosis
918
HLA Class I-Restricted and Tumor-Specific Cytotoxic T Lymphocytes from Metastatic Lymph Nodes of Esophageal Cancers
919
HLA DR/DQ type in a Malay population in Kelantan, Malaysia
920
HLA DR11 and DR12 in chronic hepatitis C: reply to Zavaglia et al.
921
HLA DRB5*01 Association Survey with Multiple Sclerosis in Khuzestan Province of Iran
922
HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells
923
HLA Genes in Atlantic Celtic populations: Are Celts Iberians?
924
HLA genes in Chimila Amerindians (Colombia), the Peopling of America and Medical implications
925
HLA genomics in the third millennium
926
HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload
927
HLA in breast cancer: its relevance for immunotherapy
928
HLA in French patients with variant Creutzfeldt-Jakob disease
929
HLA matching and outcome of heart transplantation
930
HLA MATCHMAKER: A MOLECULARLY BASED ALGORITHM FOR HISTOCOMPATIBILITY DETERMINATION
931
HLA Polymorphism in a Sample of Iraqi Acute Lymphoid Leukemia Patients
932
HLA PROFILE AND CLINICAL PRESENTATION OF MULTIPLE SCLEROSIS IN IRAN
933
HLA specificity and kidney transplantation
934
HLA supertypes and supermotifs: a functional perspective on HLA polymorphism
935
HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells
936
HLA typing from Serology to Sequencing Era
937
HLA typing in chronic type B, D and C hepatitis
938
HLA typing in Taiwanese patients with oral squamous cell carcinoma
939
HLA_ACTOR_REPAST: An approach to distributing RePast models for high-performance simulations
940
HLA-A and CTGB33 polymorphisms and variation in IQ scores
941
HLA-A Locus-Restricted and Tumor-Specific CTLs in Tumor-Infiltrating Lymphocytes of Patients with Non-Small Cell Lung Cancer
942
HLA-A*26 and Susceptibility of Iranian Patients with Non-Hodgkin Lymphoma
943
HLA-A, B (Class I) and HLA-DR, DQ (Class II) Antigens in Turkish Patients with Recurrent Aphthous Ulceration and Behçet s Disease
944
HLA-A, -B and -DR Allele and Haplotype Frequencies in the European American, African American, and Hispanic Populations in Dallas, Texas: Relatedness to the North American Population
945
HLA-A, B, C, DR and DQ expression and hepatocellular carcinoma: study of 205 Italian subjects
946
HLA-A2.1/Kb Transgenic Murine Dendritic Cells Transduced with an Adenovirus Encoding Human gp100 Process the Same A2.1-Restricted Peptide Epitopes as Human Antigen-Presenting Cells and Elicit A2.1-Restricted Peptide-Specific CTL
947
HLA-B genotype and Escherichia coli association in Iraqi patients with reactive arthritis
948
HLA-B*1502 in Iranian Children with Anticonvulsant Drugs-Induced Skin Reactions
949
HLA-B27 and Ankylosing Spondylitis geographic distribution as the result of a genetic selection induced by malaria endemic? A review supporting the hypothesis
950
HLA-B27 antigen frequency among suspected Spondyloarthropathy patients attaining a tertiary level hospital of Bangladesh
951
HLA-B27 Association with Uveitis in an Asian Indian Population
952
HLA-B27 binding of peptide from its own sequence and similar peptides from bacteria: implications for spondyloarthropathies
953
HLA-B27 Subtypes Differentially Associated with Disease Exhibit Conformational Differences in Solution
954
HLA-B51 IN BEHÇET’S DISEASE
955
HLA-C polymorphisms in two cohorts of donors for bone marrow transplantation
956
HLA-Class II in Latin American patients with type 1 diabetes
957
HLA-Cw Allele Frequency in Definite Meniere’s Disease Compared to Probable Meniere’s Disease and Healthy Controls in an Iranian Sample
958
HLA-DM and the MHC Class II Antigen Presentation Pathway
959
HLA-DM, HLA-DO and tapasin: functional similarities and differences
960
HLA-DMB expression by thyrocytes: indication of thé antigen-processing and possible presenting capability of thyroid cells
961
HLA-DP Uyumsuzluğuna Bağlı Mikst Lenfosit Kültür Testindeki Pozitiflik
962
HLA-DPB1 Variant Effect on Hepatitis B Virus Clearance and Liver Cirrhosis Development Among Southwest Chinese Population
963
HLA-DQ Genotypes in Classic Type 1 Diabetes and in Latent Autoimmune Diabetes of the Adult
964
HLADQ2 and HLADQ8 Alleles Are Associated with Celiac Disease in Children
965
HLA-DQ8 is a predisposing molecule for detergent enzyme subtilisin BPN′-induced hypersensitivity
966
HLA-DQA and DQB Alleles and Predisposition to Insulin Dependent Diabetes Mellitus
967
HLA-DQA1 and -DQB1 Alleles as Risk Factors for Acute Lymphoblastic Leukemia
968
HLA-DR alleles among Pakistani patients of coeliac disease
969
HLA-DR Binding Prediction and Experimental Evaluation of T-Cell Epitopes of Mycolyl Transferase 85B (Ag85B), a Major Secreted Antigen of Mycobacterium tuberculosis
970
HLA-DR expression and lymphocytic infiltration in metastatic and non-metastatic papillary carcinoma of the thyroid
971
HLA-DR Polymorphism and Primary Biliary Cirrhosis: Evidence From a Meta-analysis
972
HLA-DR Typing by Polymerase Chain Reaction with Sequence- Specific Primers Compared to Serological typing
973
HLA-DR, ICAM-1, CD40, CD40L, and CD86 are incorporated to a similar degree into clinical human immunodeficiency virus type 1 variants expanded in natural reservoirs such as peripheral blood mononuclear cells and human lymphoid tissue cultured ex vivo
974
HLA-DR/DQ associations with rheumatic heart disease (RHD) in Mexicans
975
HLA-DRB and HLA-DQB Allele and Haplotype Frequencies in Iranian Patients with Recurrent Aphthous Stomatitis
976
HLA-DRB and HLA-DQB loci in the genetic uceptibility to develop glaucoma in Mexican Original Reearch Article
977
HLA‑DRB1 gene polymorphisms in Iranian children with Henoch‑Schönlein purpura
978
HLA-DRB1 leprogenic motifs in Nigerian population groups
979
HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis
980
HLA-DRB1*1301 AND *1302 protect against chronic hepatitis B
981
HLA-DRB1, DQA1 and DQB1 Alleles and Haplotypes Frequencies in Iranian Healthy Adult Responders and Non-Responders to Recombinant Hepatitis B Vaccine
982
HLA-DRβ1, Circulating Th1/Th2 Cytokines and Immunological Homunculus in Coronary Atherosclerosis
983
HLA-DRβ1, Circulating Th1/Th2 Cytokines and Immunological Homunculus in Coronary Atherosclerosis
984
HLA-DR1, Circulating Th1/Th2 Cytokines and Immunological Homunculus in Coronary Atherosclerosis
985
HLA-G allele and haplotype frequencies in a healthy population of Iran.
986
HLA-G and MIC expression in tumors and their role in anti-tumor immunity
987
HLA-G expression in trophoblast cells circulating in maternal peripheral blood during early pregnancy
988
HLA-G Expression Pattern: Reliable Assessment for Pregnancy Outcome Prediction
989
HLA-G in patients with pemphigus vulgaris: does it correlate with disease severity?
990
HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia
991
HLA-G remains a mystery
992
HLA-G*0105N Null Allele Encodes Functional HLA-G Isoforms
993
HLA-G: a shield against inflammatory aggression
994
HLA-G: Facts and Fictions
995
HLA-G: from biology to clinical benefits
996
HLA-G1 increases the radiosensitivity of human tumoral cells
997
HLA-G5 and G7 Isoforms in Pregnant Women
998
HLA-H Mutations in the Ashkenazi Jewish Population
999
HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagement
1000
HLA-KIR Interactions and Immunity to Viral Infections